AIM
CYTK icon

Aigen Investment Management’s Cytokinetics CYTK Stock Holding History

Aigen Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Buy
31,216
+25,648
+461% +$1.63M 0.53% 48
2025
Q4 		$354K Buy
+5,568
New +$346K 0.08% 312
2024
Q3 		– Sell
-17,523
Closed -$949K – 787
2024
Q2 		$949K Buy
17,523
+6,870
+64% +$415K 0.18% 150
2024
Q1 		$747K Buy
+10,653
New +$824K 0.16% 193
2020
Q3 		– Sell
-46,412
Closed -$1.09M – 899
2020
Q2 		$1.09M Buy
46,412
+26,553
+134% +$498K 0.14% 234
2020
Q1 		$234K Buy
19,859
+851
+4% +$10.9K 0.03% 660
2019
Q4 		$202K Buy
+19,008
New +$195K 0.03% 549

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return